Yonsei University Wonju Christian Hospital
Welcome,         Profile    Billing    Logout  
 15 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lee, Seung-Hwan
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
ACHIEVE-4, NCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Active, not recruiting
3
2749
Europe, US, RoW
Orforglipron, LY3502970, Insulin Glargine
Eli Lilly and Company
Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease
09/25
01/26
NEPTUNE-17, NCT05838755: A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain

Active, not recruiting
2
145
Europe, Canada, Japan, US, RoW
GSK3858279, Placebo
GlaxoSmithKline
Pain
10/24
01/25
NCT06155487: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

Enrolling by invitation
1
68
RoW
AJH-2947 100 mg (SAD), Placebo, AJH-2947 200 mg (SAD), AJH-2947 300 mg (SAD), AJH-2947 400 mg (SAD), AJH-2947 600 mg (SAD), AJH-2947 800 mg (SAD), AJH-2947 200 mg (MAD), AJH-2947 400 mg (MAD), AJH-2947 600 mg (MAD)
JMackem Co., Ltd, Seoul National University Hospital
Neuropathic Pain, Diabetic Neuropathies, Post Herpetic Neuralgia
04/25
09/25
Youn, Young Jin
DAPTShort, NCT06075420: Evaluating Efficacy and Safety of Short Duration of DAPT After Genoss DES Stent Implantation in Patients

Recruiting
N/A
1000
RoW
Genoss DES stent
Genoss Co., Ltd.
Acute Coronary Syndrome, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy
12/25
12/25
DAPTLONG, NCT06075433: Evaluating Efficacy and Safety of 1-year of DAPT After Genoss DES Sirolimus-eluting Stent Implantation in Patients

Recruiting
N/A
1000
RoW
Genoss DES stent
Genoss Co., Ltd.
Coronary Artery Disease, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy
12/25
12/25
Ahn, Sung-gyun
No trials found
Lee, Jun-Won
No trials found

Download Options